Tempus AI, Inc.شراء
TEM - Nov 24 Extended Mispriced Assets
تم تحديثه
Strategy - Extended Mispriced Assets 🌊
Idea
TEM, a precision medical AI company recently listed on June 14, 2024, and featured on The Wall Street Journal, has demonstrated consistent growth over the past three quarters with improving EPS.
Despite these strong fundamentals and a clear thematic focus on AI, TEM has been downtrending along with the broader market following the Trump rally. On November 21, it experienced a sharp bearish move, which appears to be tied to the broader market’s negative reaction to Nvidia's strong earnings.
Given its robust business fundamentals and alignment with the AI growth narrative, I believe TEM is currently mispriced, presenting an opportunity to arbitrage this value as it normalises.
Technical positioning
- Confluence in RUT & SPX bull direction
- Recent price consolidation below H1 100SMA
- Trade is aligned to existing trend
- Risk reward is 2.9R at the 12 Nov
Idea
TEM, a precision medical AI company recently listed on June 14, 2024, and featured on The Wall Street Journal, has demonstrated consistent growth over the past three quarters with improving EPS.
Despite these strong fundamentals and a clear thematic focus on AI, TEM has been downtrending along with the broader market following the Trump rally. On November 21, it experienced a sharp bearish move, which appears to be tied to the broader market’s negative reaction to Nvidia's strong earnings.
Given its robust business fundamentals and alignment with the AI growth narrative, I believe TEM is currently mispriced, presenting an opportunity to arbitrage this value as it normalises.
Technical positioning
- Confluence in RUT & SPX bull direction
- Recent price consolidation below H1 100SMA
- Trade is aligned to existing trend
- Risk reward is 2.9R at the 12 Nov
تم فتح الصفقة
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences (21 Nov, 8:02PM after market close)
In a significant move, ARK invested heavily in Tempus AI, purchasing 126,424 shares across its ARKK and ARKG ETFs, amounting to a substantial $7,351,555. This purchase represents the largest dollar-value trade by ARK for the day and underscores the fund's growing interest in the artificial intelligence-driven biotech company.
investing.com/news/company-news/cathie-woods-ark-buys-tempus-ai-stock-sells-exact-sciences-93CH-3736372
أغلقت الصفقة: تم الوصول لوقف الخسارة
Trailing 2 day low stop hit. We captured 1.65R which is 11.66% but max run up was 25.96% wow
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.